Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2018, Vol. 23 ›› Issue (10): 1179-1187.doi: 10.12092/j.issn.1009-2501.2018.10.015

Previous Articles     Next Articles

Progress of proton pump inhibitors using in cancer patients

HUANG Qiong, DU Jie, CHENG Shuqiao, GONG Zhicheng   

  1. Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China
  • Received:2018-08-15 Revised:2018-09-17 Online:2018-10-26 Published:2018-10-25

Abstract:

Proton pump inhibitors (PPIs) are a class of drugs that inhibit gastric acid secretion. They are used in the treatment of acute and chronic digestive diseases. They are also commonly used in chemical therapy, radiation therapy, stress ulcers and prophylactic administration of steroids. In clinical research, it is found that most of the preventive administrations of PPIs are unreasonable. This article reviews the clinical trials and adverse reactions of PPIs in cancer patients, providing a reference for rational use of PPIs.

Key words: proton pump inhibitors, cancer, chemotherapy, steroids, drug interactions

CLC Number: